134 related articles for article (PubMed ID: 37771187)
1. Yin Yang 1 promotes the neuroendocrine differentiation of prostate cancer cells via the non-canonical WNT pathway (FYN/STAT3).
Liu RJ; Xu ZP; Huang X; Xu B; Chen M
Clin Transl Med; 2023 Oct; 13(10):e1422. PubMed ID: 37771187
[TBL] [Abstract][Full Text] [Related]
2. hnRNPM, a potential mediator of YY1 in promoting the epithelial-mesenchymal transition of prostate cancer cells.
Yang T; An Z; Zhang C; Wang Z; Wang X; Liu Y; Du E; Liu R; Zhang Z; Xu Y
Prostate; 2019 Aug; 79(11):1199-1210. PubMed ID: 31251827
[TBL] [Abstract][Full Text] [Related]
3. Abi1 loss drives prostate tumorigenesis through activation of EMT and non-canonical WNT signaling.
Nath D; Li X; Mondragon C; Post D; Chen M; White JR; Hryniewicz-Jankowska A; Caza T; Kuznetsov VA; Hehnly H; Jamaspishvili T; Berman DM; Zhang F; Kung SHY; Fazli L; Gleave ME; Bratslavsky G; Pandolfi PP; Kotula L
Cell Commun Signal; 2019 Sep; 17(1):120. PubMed ID: 31530281
[TBL] [Abstract][Full Text] [Related]
4. FZD8, a target of p53, promotes bone metastasis in prostate cancer by activating canonical Wnt/β-catenin signaling.
Li Q; Ye L; Zhang X; Wang M; Lin C; Huang S; Guo W; Lai Y; Du H; Li J; Song L; Peng X
Cancer Lett; 2017 Aug; 402():166-176. PubMed ID: 28602974
[TBL] [Abstract][Full Text] [Related]
5. MiR-142-5p Suppresses Lung Cancer Cell Metastasis by Targeting Yin Yang 1 to Regulate Epithelial-Mesenchymal Transition.
Zhang Q; Liu H; Zhang J; Shan L; Yibureyimu B; Nurlan A; Aerxiding P; Luo Q
Cell Reprogram; 2020 Dec; 22(6):328-336. PubMed ID: 33270501
[TBL] [Abstract][Full Text] [Related]
6. CRTAC1 (Cartilage acidic protein 1) inhibits cell proliferation, migration, invasion and epithelial-mesenchymal transition (EMT) process in bladder cancer by downregulating Yin Yang 1 (YY1) to inactivate the TGF-β pathway.
Yang J; Fan L; Liao X; Cui G; Hu H
Bioengineered; 2021 Dec; 12(2):9377-9389. PubMed ID: 34818994
[TBL] [Abstract][Full Text] [Related]
7. Salt-like transcription factor 4 promotes laryngeal cancer progression through transcriptional activation of ubiquitin-specific protease 21 to stabilize Yin Yang 1.
Wang QD; Liu LL; Li D; Gao L; Zhang MJ
Pathol Int; 2023 Mar; 73(3):109-119. PubMed ID: 36285444
[TBL] [Abstract][Full Text] [Related]
8. Involvement of Yin Yang 1 (YY1) Expression in T-Cell Subsets Differentiation and Their Functions: Implications in T Cell-Mediated Diseases.
Kosasih FR; Bonavida B
Crit Rev Immunol; 2019; 39(6):491-510. PubMed ID: 32421959
[TBL] [Abstract][Full Text] [Related]
9. Tumor protein D52 (isoform 3) induces NF-κB - STAT3 mediated EMT driving neuroendocrine differentiation of prostate cancer cells.
Sruthi KK; Natani S; Ummanni R
Int J Biochem Cell Biol; 2024 Jan; 166():106493. PubMed ID: 37935328
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA SNHG14 promotes malignancy of prostate cancer by regulating with miR-5590-3p/YY1 axis.
Luo ZF; Peng Y; Liu FH; Ma JS; Hu G; Lai SL; Lin H; Chen JJ; Zou GM; Yan Q; Sui WG
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4697-4709. PubMed ID: 32432733
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-147b induces neuroendocrine differentiation of prostate cancer cells by targeting ribosomal protein RPS15A.
Natani S; Ramakrishna M; Nallavolu T; Ummanni R
Prostate; 2023 Jul; 83(10):936-949. PubMed ID: 37069746
[TBL] [Abstract][Full Text] [Related]
12. Depletion of enhancer zeste homolog 2 (EZH2) directs transcription factors associated with T cell differentiation through epigenetic regulation of Yin Yang 1(YY1) in combating non-small cell lung cancer (NSCLC).
Chandnani N; Choudhari VS; Talukdar R; Rakshit S; Shanmugam G; Guchait S; Gupta I; George M; Sarkar K
Med Oncol; 2023 May; 40(7):185. PubMed ID: 37212947
[TBL] [Abstract][Full Text] [Related]
13. The Role of Epigenetic Change in Therapy-Induced Neuroendocrine Prostate Cancer Lineage Plasticity.
Storck WK; May AM; Westbrook TC; Duan Z; Morrissey C; Yates JA; Alumkal JJ
Front Endocrinol (Lausanne); 2022; 13():926585. PubMed ID: 35909568
[TBL] [Abstract][Full Text] [Related]
14. Positive and negative regulation of prostate stem cell antigen expression by Yin Yang 1 in prostate epithelial cell lines.
Tang S; Mishra M; Frazier DP; Moore ML; Inoue K; Deora R; Sui G; Dubey P
PLoS One; 2012; 7(4):e35570. PubMed ID: 22536409
[TBL] [Abstract][Full Text] [Related]
15. Yin Yang 1 regulates ITGAV and ITGB1, contributing to improved prognosis of colorectal cancer.
Sato N; Sakai N; Furukawa K; Takayashiki T; Kuboki S; Takano S; Ohira G; Matsubara H; Ohtsuka M
Oncol Rep; 2022 May; 47(5):. PubMed ID: 35266011
[TBL] [Abstract][Full Text] [Related]
16. YY1 complex in M2 macrophage promotes prostate cancer progression by upregulating IL-6.
Chen S; Lu K; Hou Y; You Z; Shu C; Wei X; Wu T; Shi N; Zhang G; Wu J; Chen S; Zhang L; Li W; Zhang D; Ju S; Chen M; Xu B
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37094986
[TBL] [Abstract][Full Text] [Related]
17.
Bhagirath D; Yang TL; Tabatabai ZL; Majid S; Dahiya R; Tanaka Y; Saini S
Clin Cancer Res; 2019 Nov; 25(21):6532-6545. PubMed ID: 31371344
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the transcription factor Yin Yang 1 activity by S-nitrosation.
Hongo F; Garban H; Huerta-Yepez S; Vega M; Jazirehi AR; Mizutani Y; Miki T; Bonavida B
Biochem Biophys Res Commun; 2005 Oct; 336(2):692-701. PubMed ID: 16143308
[TBL] [Abstract][Full Text] [Related]
19. Wnt activator FOXB2 drives the neuroendocrine differentiation of prostate cancer.
Moparthi L; Pizzolato G; Koch S
Proc Natl Acad Sci U S A; 2019 Oct; 116(44):22189-22195. PubMed ID: 31611391
[TBL] [Abstract][Full Text] [Related]
20. Yin Yang 1 contributes to gastric carcinogenesis and its nuclear expression correlates with shorter survival in patients with early stage gastric adenocarcinoma.
Kang W; Tong JH; Chan AW; Zhao J; Dong Y; Wang S; Yang W; Sin FM; Ng SS; Yu J; Cheng AS; To KF
J Transl Med; 2014 Mar; 12():80. PubMed ID: 24674326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
